Congenital insensitivity to pain in a 1-year-old boy

Area of Science:

• Genetics
• Neurology
• Pediatrics

Background:

• Congenital insensitivity to pain (CIP) is a rare autosomal recessive disorder characterized by reduced pain and thermal sensation.
• CIP can lead to severe injuries, self-mutilation, and psychological issues due to the inability to perceive pain.
• Early diagnosis and management are crucial for improving patient outcomes and quality of life.

Observation:

• A case report details an infant presenting with clinical features indicative of CIP.
• The infant exhibited minimal response to pain stimuli and demonstrated self-mutilating behaviors.
• Associated symptoms included significant developmental delays and intellectual disability.

Findings:

• Genetic analysis revealed a mutation in exon 5 of the PRDM12 gene in the affected infant.
• This mutation is strongly associated with the observed clinical phenotype of CIP.
• The PRDM12 gene plays a critical role in pain perception pathways and neurodevelopment.

Implications:

• This case highlights the importance of genetic testing in diagnosing CIP, particularly in infants with unexplained pain insensitivity and self-mutilation.
• Identifying the specific gene mutation (PRDM12) provides insights into the molecular mechanisms underlying CIP.
• Further research into PRDM12 function could lead to novel therapeutic strategies for pain disorders and related neurological conditions.